Evan Ehrenberg

Member Since 2020

Evan Ehrenberg

CEO

Clara Health

San Francisco Bay Area

After graduating from UC Berkeley at 16, Evan became the youngest ever neuroscience Ph.D. at MIT. Before Clara, he managed AI research for over a decade at MIT, Cal, and Palantir. Evan is a USERN ambassador and recipient of the Forbes 30 Under 30 award.

SKILLS

  • Research
  • Neuroscience
  • Computer Vision

COMPANY INFO

Clara Health

Patients can benefit from clinical trials. And researchers need 1 in 8 Americans to participate in trials to bring new treatments to reality. So why aren't these two groups connecting? At Clara, we're answering the call. We're building the best patient experience for anyone looking to connect to any trial. And we're equipping researchers with the tools and knowledge they need to recruit for their trials in a truly patient-centric way. By giving both sides tools that are built for the 21st century, we're helping accelerate breakthrough research. If you'd like to work with us in bringing better tools to your research team, just shoot us a message at team@clarahealth.com.

AREA OF FOCUS

  • Clinical Trials
  • Patient Centered Care
  • Patient Advocacy

INDUSTRY

Health

© 2023 Newsweek Forum, LLC. All rights reserved. | Terms and Conditions and Privacy Policy | Newsweek® and the other denoted terms and the related trade dress are a non-exclusive list of the trademarks of Newsweek, LLC. in the U.S. and/or other countries. Newsweek, LLC trademarks and trade dress may not be used in connection with any product or service that is not Newsweek, LLC, in any manner that is likely to cause confusion among customers, or any manner that disparages Newsweek, LLC. This site contains the trademarks, service marks, and logos of third parties and such trademarks and service marks are the property of their respective owners and not owned by Newsweek, LLC. Such third party trademark owners may or may not be affiliated with, connected to, or sponsored by Newsweek, LLC. These third party marks include but are not limited to Newsweek®, which is a registered trademark of and the property of Newsweek, LLC.